Gregor Mack previously completed an MEng in Biomedical Engineering from the University of Strathclyde, Glasgow (UK) in 2020. During this time he gained a diverse skillset through completion of 3 projects: the development of hydrogel-based artificial arteries and measurement of drug kinetics for arterial stent coating optimisation; design and testing of a novel biomechanics tracking device for human gait analysis; and a collaborative project designing a microfluidic device for anti-cancer drug screening.
Currently, he is undertaking a Centre for Doctoral Training (CDT) PhD program in Advanced Biomedical Materials at The University of Manchester (UK) with Prof. Philip Morgan, and in collaboration with Dr. Mouad Lamrani of Menicon Co., Ltd (R&D Innovation Centre, Geneva, Switzerland). His PhD research is split between engineering, biomaterials and optometry fields, and involves the exploration, manipulation and characterisation of copolymers to engineer novel contact lens materials. In particular, the study of their interactions with tear film proteins. The overarching goal of his work is to develop new hydrogel materials that can be safely used in the ocular environment for a wider range of ophthalmic applications in the future.
Gregor’s research interests lie in the design, development, and testing of novel point-of-care diagnostic and therapeutic medical devices for healthcare applications. He has presented his work at a number of academic conferences, one of which he was awarded best poster prize (Joint TCES/EPSRC CDT Conference 2022).